SpringWorks Therapeutics, Inc.
SWTX
$37.06
-$0.86-2.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -44.40% | -34.10% | 54.32% | 7.35% | -18.74% |
| Total Depreciation and Amortization | 15.83% | 4.03% | 15.78% | 35.50% | 8.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.16% | -0.04% | -10.73% | 16.47% | 11.47% |
| Change in Net Operating Assets | 1,682.53% | 96.22% | -29.05% | -753.00% | -5.64% |
| Cash from Operations | -16.24% | 39.27% | 47.05% | -25.88% | -24.26% |
| Capital Expenditure | 43.04% | -89.44% | -68.98% | -125.07% | 163.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.17% | 2,312.58% | -94.26% | 113.65% | -522.56% |
| Cash from Investing | -50.62% | 9,812.80% | -98.65% | 113.48% | -560.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -34.30% | -58.28% | -27.84% | -98.01% | 1,360,463.64% |
| Repurchase of Common Stock | -4.81% | 45.70% | 85.86% | -2,467.98% | 4.17% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -49.42% | -61.70% | 710.69% | -100.18% | 123,683.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -422.41% | 111.96% | 34.28% | -175.19% | 579.14% |